The Leadership Team at IGM Biosciences oversees the strategic direction and operational management of the company, focusing on the development and commercialization of innovative IgM antibody therapies. Comprised of executive leaders from diverse backgrounds, the team guides research and development efforts, regulatory strategies, and market positioning, while ensuring alignment with the company's mission to advance treatments for various malignancies and autoimmune conditions. Additionally, they foster collaboration across departments to drive innovation and operational efficiency.
Angus M. Sinclair
SVP, Immuno-Oncology
Bruce Keyt
Chief Scientific Officer
Carrie Brodmerkel
Chief Scientific Officer, IGM ...
Elizabeth Haanes
SVP, Intellectual Property
Lisa L. Decker
Chief Business Officer
Marvin S. Peterson
EVP, Process Development & Man...
Misbah Tahir
CFO
Suzette Tauber
Chief Human Resources Officer
View all